NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host

The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International…

Read more

In the Pink: Preventing Breast Cancer in Every Season of Life

As the tidal wave of pink paraphernalia synonymous with October ebbs, and our thoughts turn to turkey, football and autumn foliage in full Technicolor array; it’s important to keep in mind that preventing breast cancer is a year-round affair. Vigilance…

Read more

Outrunning Cancer: Exercise is the Best “Medicine”

Many common cancer treatments and surgeries are invasive and have uncomfortable or painful side-effects which make movement and participation in even the most basic of activities a challenge. Patients are traditionally told to take it easy after being diagnosed or…

Read more

Genetic Marker Can Help Focus Prostate Cancer Therapies

CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that…

Read more

Firefighters: Heroes in the Line of Fire

All consuming, unforgiving, destructive: adjectives easily attributable to the symptoms, treatments, diagnosis and battle with cancer. These descriptors also paint an accurate rendering of the infernos into which American fire fighters, America’s Bravest, venture unflinchingly as they perform their duty.…

Read more

Take a Bite Out of Cancer: Foods that Fail

Eating well and living an active lifestyle are important. If we want to live our best lives, and if we’re looking to take a proactive approach to preventing a cancer diagnosis, then how and what we eat is of great…

Read more

Novel CAR-T Treatment Approved for Second Indication

In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October…

Read more

Fall 2017 | Top Ten Fundraisers as of October 31

In the name of friendly competition, we’re highlighting our top ten fundraisers so far this fall as a way to honor and acknowledge the teams who work so hard to support Play4TheCure. Please note that this list only represents teams…

Read more

NFCR President and COO to co-organize and speak at SNOChina 2018

The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the president and chief operating officer of the National Foundation for Cancer Research (NFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha,…

Read more

Infectious Disease Agents as a Cause of Cancer

Cancer is a group of diseases defined by abnormal cell growth and caused by genetic defects. Most of us know that these genetic defects can be inherited, caused by environmental factors such as smoking, drinking, obesity and a lack of…

Read more

Take a Bite Out Of Cancer: Foods that Fight Cancer

Fuel is important and our choices in fuel are equally so. We put high-test in our cars, buy organic milk for our children and we obsess about our coffee! If we’re willing to go to these lengths, why not be…

Read more

New Compound Targets Metastatic Cancer Cells

​Scientists​ ​at​ ​Bar-Ilan​ ​University​ ​in​ ​Israel​ ​successfully​ ​targeted​ ​and​ ​rendered​ ​inert​ ​the​ ​enzyme that metastatic​ ​cancer​ ​cells​ ​need​ ​to​ ​survive​ ​in​ ​the​ ​body​ ​once​ ​they​ ​have​ ​left​ ​their​ ​host​ ​tumor.​ ​

Read more